382 filings
Page 4 of 20
8-K
4klgnafd6hmr dx
17 Jan 19
Spectrum will receive $160 million in an upfront cash payment and up to $140 million in regulatory and sales-based milestones
7:57am
8-K
oedwt7b6hnh syfddr
7 Jan 19
Regulation FD Disclosure
9:01am
8-K
3jc7hlo
19 Dec 18
Spectrum Pharmaceuticals Provides Poziotinib Update
4:02pm
8-K
l4yahfbuw0yf3c5f
13 Nov 18
Departure of Directors or Certain Officers
7:00am
8-K
olapn5 ivvw814the4
8 Nov 18
Spectrum Pharmaceuticals Reports Third Quarter 2018 Pipeline Update and Financial Results
4:03pm
8-K
ewjtp5moilqjkk6n1h
9 Aug 18
Spectrum Pharmaceuticals Reports Second Quarter 2018 Financial Results and Pipeline Update
4:05pm
8-K
mkn795nuh8jrs1xobq3
18 Jun 18
Departure of Directors or Certain Officers
4:10pm
8-K
zbhrwtq5ifc3f
3 May 18
Spectrum Pharmaceuticals Reports First Quarter 2018 Financial Results and Pipeline Update
4:03pm
8-K
kodakwm9y ofh1wfg9u8
16 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
nitws8 uodb3s0qju
29 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
e1tmxxez51v1 0lq
20 Mar 18
Other Events
12:00am
8-K
jc7 4mvkdjtu8ez8m5l
6 Mar 18
Spectrum Pharmaceuticals Reports Fourth Quarter 2017 and Full Year 2017 Financial Results and Pipeline Update
12:00am
8-K
9yci4zumi52n6
27 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
zyhertwa818i a16og
19 Jan 18
Departure of Directors or Certain Officers
12:00am
8-K
gos8in8hb
8 Jan 18
Spectrum Pharmaceuticals Joseph Turgeon President and Chief Executive Officer January 2018 Investor Presentation
12:00am
8-K
bybpyz3 l9may4
21 Dec 17
Regulation FD Disclosure
12:00am
8-K
esc7tj8yw 2p5p82o
18 Dec 17
Spectrum Pharmaceuticals Announces Leadership Changes
12:00am
8-K
p66251e0 9hmpj57
2 Nov 17
Spectrum Pharmaceuticals Reports Third Quarter 2017 Financial Results and Pipeline Update
12:00am
8-K
l6gdpwl93ye
18 Oct 17
Regulation FD Disclosure
12:00am
8-K
chnjjrm8c5krkw
13 Oct 17
Entry into a Material Definitive Agreement
12:00am